SYNAPSE BIOMEDICAL NEURX DIAPHRAGM PACING SYSTEM 20-0035

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2016-07-19 for SYNAPSE BIOMEDICAL NEURX DIAPHRAGM PACING SYSTEM 20-0035 manufactured by Synapse Biomedical Inc..

Event Text Entries

[49910725] The company's chief medical officer (a physician) spoke to the attending cardiologist at the hospital and they believe that the device may have contributed to some of the arrhythmias observed, which is a known potential device risk, but the device did not contribute to the patient's death.
Patient Sequence No: 1, Text Type: N, H10


[49910726] The patient was a (b)(6) year old female who suffered a c5-c7 spinal cord injury following surgical resection of a cyst on her spine leaving her with quadriplegia. She was successfully implanted with the diaphragm pacing system (b)(6) 2013. In 2016 the patient's health began to decline and she was hospitalized earlier in the year (precise date(s) unknown) for treatment of sma syndrome due to recent significant weight loss. No cardiac arrhythmias were noted during that stay and the patient was discharged. The patient further declined and was readmitted to the same hospital in (b)(6) 2016 with bilateral pulmonary emboli and hydronephrosis, which were treated. It was noted that when the diaphragm pacer was turned on and she went from positive chest pressure ventilation to negative chest pressure ventilation she consistently developed ventricular couplets and at one point experienced ventricular tachycardia. At that time all diaphragm pacing was discontinued and ventilation was maintained by mechanical ventilation alone through her tracheostomy. An echocardiogram performed at the time showed increased pulmonary pressures consistent with her pulmonary emboli and no pericardial fluid was noted. The patient continued to deteriorate and further arrhythmias were observed. The family then decided to withdraw further support and the patient expired.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005868392-2016-00002
MDR Report Key5804354
Report SourceHEALTH PROFESSIONAL
Date Received2016-07-19
Date of Report2016-07-08
Date of Event2016-06-08
Date Mfgr Received2016-06-08
Device Manufacturer Date2013-08-08
Date Added to Maude2016-07-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. MARK BARBUTES
Manufacturer Street300 ARTINO STREET
Manufacturer CityOBERLIN OH 44074
Manufacturer CountryUS
Manufacturer Postal44074
Manufacturer Phone4407742488
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSYNAPSE BIOMEDICAL NEURX DIAPHRAGM PACING SYSTEM
Generic NameDIAPHRAGM PACER
Product CodeOIR
Date Received2016-07-19
Model Number20-0035
Lot Number20-0035-080813-3-2
Device Expiration Date2015-04-30
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSYNAPSE BIOMEDICAL INC.
Manufacturer Address300 ARTINO STREET OBERLIN OH 44074 US 44074


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-07-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.